The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.
about
Otelixizumab: a novel agent for the prevention of type 1 diabetes mellitus.Tolerance induction as a therapeutic strategy for the control of autoimmune endocrine disease in mouse models.Pathogenesis of IDDM: immune regulation and induction of immune tolerance in the NOD mouse.Mononuclear cytotoxicity and proliferation towards glucose stimulated rodent pancreatic islet cells.
P2860
The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The differentiation of the imm ...... oimmunity. Clinical prospects.
@ast
The differentiation of the imm ...... oimmunity. Clinical prospects.
@en
type
label
The differentiation of the imm ...... oimmunity. Clinical prospects.
@ast
The differentiation of the imm ...... oimmunity. Clinical prospects.
@en
prefLabel
The differentiation of the imm ...... oimmunity. Clinical prospects.
@ast
The differentiation of the imm ...... oimmunity. Clinical prospects.
@en
P2860
P356
P1433
P1476
The differentiation of the imm ...... oimmunity. Clinical prospects.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF00401362
P577
1992-12-01T00:00:00Z